Literature DB >> 10395932

Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene.

C P Tensen1, J Flier, S S Rampersad, S Sampat-Sardjoepersad, R J Scheper, D M Boorsma, R Willemze.   

Abstract

CXCL 11, encoded by the cDNA sequences designated beta-R1, H-174, or I-TAC, is a CXC chemokine ligand for CXCR3 and assumed to be involved in inflammatory diseases characterized by the presence of activated T-cells. We here describe the genomic organization (four exons interrupted by three introns of 585, 98 and 230 bp) and sequence including 960 bp from the immediate 5'-upstream region of the human CXCL 11 gene. Within the promoter region, consensus sequences for regulatory elements (ISRE, GAS, NF-kappaB) important for cytokine-induced gene transcription were identified. The effect of (pro)inflammatory cytokines on CXCL 11 mRNA expression in monocytic cell lines (THP-1, U937) and primary cultures of dermal fibroblasts and endothelial cells were examined using Northern blot analysis. For these cell types, IFN-gamma was a potent inducer of CXCL 11 transcription, which was synergistically enhanced by TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395932     DOI: 10.1016/s0167-4781(99)00084-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

2.  The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.

Authors:  Sujata Balasubramanian; Meiyun Fan; Angela F Messmer-Blust; Chuan H Yang; Jill A Trendel; Jonathan A Jeyaratnam; Lawrence M Pfeffer; Deborah J Vestal
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

3.  Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Authors:  Karla J Helbig; Andrew Ruszkiewicz; Robert E Lanford; Mark D Berzsenyi; Hugh A Harley; Shaun R McColl; Michael R Beard
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

4.  Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.

Authors:  Ellen Witte; Georgios Kokolakis; Katrin Witte; Katarzyna Warszawska; Markus Friedrich; Demetrios Christou; Stefan Kirsch; Wolfram Sterry; Hans-Dieter Volk; Robert Sabat; Kerstin Wolk
Journal:  J Mol Med (Berl)       Date:  2015-11-26       Impact factor: 4.599

5.  Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.

Authors:  Daryle Depianto; Michelle L Kerns; Andrzej A Dlugosz; Pierre A Coulombe
Journal:  Nat Genet       Date:  2010-09-26       Impact factor: 38.330

6.  Organization and promoter analysis of the zebrafish (Danio rerio) chemokine gene (CXC-64) promoter.

Authors:  Li-Chen Chen; Jen-Leih Wu; Chyuan-Yuan Shiau; Jyh-Yih Chen
Journal:  Fish Physiol Biochem       Date:  2009-04-18       Impact factor: 2.794

7.  Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-Armstrong.

Authors:  Markus J Hofer; Sally L Carter; Marcus Müller; Iain L Campbell
Journal:  Viral Immunol       Date:  2008-12       Impact factor: 2.257

8.  Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid.

Authors:  Savita Khanna; Han-A Park; Chandan K Sen; Trimurtulu Golakoti; Krishanu Sengupta; Somepalli Venkateswarlu; Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

9.  The role of chemokines in acute liver injury.

Authors:  Yedidya Saiman; Scott L Friedman
Journal:  Front Physiol       Date:  2012-06-20       Impact factor: 4.566

10.  Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.

Authors:  Qiong Fu; Xiaoqing Chen; Huijuan Cui; Yanzhi Guo; Jing Chen; Nan Shen; Chunde Bao
Journal:  Arthritis Res Ther       Date:  2008-09-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.